Israel

Use of U.S.-Manufactured Tear Gas in the Occupied Territories Gao ID: NSIAD-89-128 April 13, 1989

In response to a congressional request, GAO reviewed the Israeli Defense Forces' (IDF) use of U.S.-manufactured tear gas in the Palestinian-occupied territories of the West Bank and Gaza, focusing on: (1) medical evidence on the effects of tear gas; (2) U.S. laws and policies relating to tear gas exports and their application to restrict tear gas exports on other occasions; and (3) the Department of State's rationale in considering allegations of IDF tear gas misuse and whether such exports should continue.

GAO found that: (1) in 1988, State received various allegations that IDF misused tear gas designed for outdoor use by throwing it into enclosed spaces or aiming it directly into crowds; (2) medical evidence generally concluded that, when properly handled, tear gas was one of the most humane forms of riot control and was intended for crowd dispersal, rather than for punishment; (3) although State had not invoked export sanctions on any particular country, it had disapproved individual license applications for exports to various countries, including applications for the sale of tear gas; (4) although State reviewed specific allegations of IDF tear gas misuse in the occupied territories, there was insufficient evidence to suspend tear gas exports; and (5) the U.S. manufacturer suspended tear gas sales to Israel for a 4-month period in 1988 until Israel provided assurances of proper usage.



The Justia Government Accountability Office site republishes public reports retrieved from the U.S. GAO These reports should not be considered official, and do not necessarily reflect the views of Justia.